Market Overview:
The global eyedrops market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of eye diseases, rising awareness about eye care, and technological advancements in the field of ophthalmology. In addition, growing demand for over-the-counter (OTC) eyedrops is also contributing to the growth of this market. On the basis of type, antibiotics eyedrops are expected to dominate the global market during the forecast period. This can be attributed to their high efficacy in treating various eye infections and diseases. Hormonal eyedrops are also anticipated to witness significant growth during the forecast period owing to their ability to treat various vision problems such as dry eyes and cataracts. By application, eye disease segment is estimated account for majority share in terms revenue generated by global Eyedrop Market during 2018-2030 .This can be majorly accredited towards increase incidences off Eye Diseases across globe which will further boost demand for eyecare products including Eyedrop s globally over next decade . Regionally , North America accounted largest revenue generating region followed by Europe due higher adoption rate off advanced technologies coupled with presence key players operating within this region .
Product Definition:
Eyedrops are a medication that is placed into the eyes. They are used to treat a variety of conditions, including dry eyes, allergies, and infections.
Antibiotics Eyedrops:
Antibiotics are medicines used to treat bacterial infections. The most common types of bacterial infections are cold sores, skin wounds, urinary tract infections (UTIs), and earaches. Antibiotics can be administered in the form of eye drops or oral tablets. They can also be used as a cream or injection.
Hormonal Eyedrops:
Hormonal eyedrops are medicines that are used to reduce or eliminate droopy eyes, also called meibomian gland dysfunction (MGD), it is a condition wherein the oil glands in the eyes produce too much mucus which results in vision problems. The most common symptom of MGD is excessive tearing. Hormonal eye drops help to reduce/eliminate excessive tearing and improve vision.
Application Insights:
The others segment held the largest share of more than 50.0% in 2017. The application includes diabetic retinopathy, macular degeneration and glaucoma. According to a study published in NCBI, around 54 million people are affected by diabetic retinopathy across the globe which is expected to increase by around 12% from 2016 to 2030 leading to blindness in approximately 2120 million people.
On the other hand, according to WHO over 60 million people are suffering from glaucoma globally which is expected to increase by over 1% annually until 2040 resulting in nearly 17 million cases of glaucoma worldwide every year by then. Thus, due largelyto increasing patient base and prevalence of eye diseases coupled with rising geriatric population there will be huge demand for eyedrops during forecast period thereby driving market growth during this period.
Regional Analysis:
Europe dominated the global market in 2017. The presence of well-developed healthcare infrastructure, high purchasing power parity, and prevalence of eye diseases are some major factors responsible for its large share. In addition, rise in awareness about various treatment options is expected to drive demand over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing geriatric population and rising disposable income coupled with growing medical tourism industry in emerging economies such as India and China. Moreover, increase in R&D activities by leading eyecare companies for development of innovative products will also support regional market growth over the next eight years.
The product portfolio offered by these players includes a wide range of generic drugs along with branded formulations that cater to different target populations across geographies; this offers them a competitive edge over other local manufacturers who do not have access to such resources or expertise at hand (i).
Growth Factors:
- Increasing prevalence of eye diseases and disorders: The increasing prevalence of various eye diseases and disorders is one of the key growth drivers for the eyeglasses market. According to a study by the World Health Organization (WHO), over 285 million people across the globe were affected by visual impairment in 2010, out of which 246 million were cases of uncorrected refractive errors. This number is expected to increase to 380 million by 2020. Thus, there is a growing demand for eyeglasses and other vision correction products such as contact lenses and eyedrops.
- Rising awareness about eye care: There has been a rising awareness about eye care in recent years, owing to increasing incidences of blindness and other vision-related problems across the world. This has led to an increase in demand for corrective lenses, eyeglasses, contact lenses, and other ophthalmic products such as eyedrops.
- Technological advancements: The advent of new technologies has led to significant advancements in ophthalmic devices such as contact lenses, spectacles frames etc., which are now available in different shapes, sizes colors with advanced features that provide better comfortability and aesthetics than ever before .This is likely to boost demand for these devices among consumers worldwide thereby propelling growth prospects for the global eyedrops market during the forecast period 2016-2024 .
Scope Of The Report
Report Attributes
Report Details
Report Title
Eyedrops Market Research Report
By Type
Antibiotics Eyedrops, Hormonal Eyedrops, Health Care Eyedrops
By Application
Eye Disease, Eye Care, Others
By Companies
Ursapharm, Santen, Bayer Inc., Abbott, Allergan, Bausch & Lomb, Johnson & Johnson, Rohto Pharmaceutical, The United Laboratories, Alcon, Novax Pharma, Rohto, Clear Eyes, Thea Pharmaceuticals, Scope Ophthalmics Ltd, Prestige Consumer Healthcare, Medicom Healthcare Ltd, Altacor, Optrex, Sager Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
219
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Eyedrops Market Report Segments:
The global Eyedrops market is segmented on the basis of:
Types
Antibiotics Eyedrops, Hormonal Eyedrops, Health Care Eyedrops
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Eye Disease, Eye Care, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ursapharm
- Santen
- Bayer Inc.
- Abbott
- Allergan
- Bausch & Lomb
- Johnson & Johnson
- Rohto Pharmaceutical
- The United Laboratories
- Alcon
- Novax Pharma
- Rohto
- Clear Eyes
- Thea Pharmaceuticals
- Scope Ophthalmics Ltd
- Prestige Consumer Healthcare
- Medicom Healthcare Ltd
- Altacor
- Optrex
- Sager Pharma
Highlights of The Eyedrops Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibiotics Eyedrops
- Hormonal Eyedrops
- Health Care Eyedrops
- By Application:
- Eye Disease
- Eye Care
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Eyedrops Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Eyedrops are a type of medication that is used to relieve the symptoms of dry eyes. They are usually made from a mixture of water and an eyedropper-like device. The dropper is inserted into the eye and then squeezed to release the liquid.
Some of the key players operating in the eyedrops market are Ursapharm, Santen, Bayer Inc., Abbott, Allergan, Bausch & Lomb, Johnson & Johnson, Rohto Pharmaceutical, The United Laboratories, Alcon, Novax Pharma, Rohto, Clear Eyes, Thea Pharmaceuticals, Scope Ophthalmics Ltd, Prestige Consumer Healthcare, Medicom Healthcare Ltd, Altacor, Optrex, Sager Pharma.
The eyedrops market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Eyedrops Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Eyedrops Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Eyedrops Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Eyedrops Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Eyedrops Market Size & Forecast, 2020-2028
4.5.1 Eyedrops Market Size and Y-o-Y Growth
4.5.2 Eyedrops Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Antibiotics Eyedrops
5.2.2 Hormonal Eyedrops
5.2.3 Health Care Eyedrops
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Eye Disease
6.2.2 Eye Care
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Eyedrops Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Eyedrops Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Antibiotics Eyedrops
9.6.2 Hormonal Eyedrops
9.6.3 Health Care Eyedrops
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Eye Disease
9.10.2 Eye Care
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Antibiotics Eyedrops
10.6.2 Hormonal Eyedrops
10.6.3 Health Care Eyedrops
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Eye Disease
10.10.2 Eye Care
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Antibiotics Eyedrops
11.6.2 Hormonal Eyedrops
11.6.3 Health Care Eyedrops
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Eye Disease
11.10.2 Eye Care
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Antibiotics Eyedrops
12.6.2 Hormonal Eyedrops
12.6.3 Health Care Eyedrops
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Eye Disease
12.10.2 Eye Care
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Antibiotics Eyedrops
13.6.2 Hormonal Eyedrops
13.6.3 Health Care Eyedrops
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Eye Disease
13.10.2 Eye Care
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Eyedrops Market: Competitive Dashboard
14.2 Global Eyedrops Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Ursapharm
14.3.2 Santen
14.3.3 Bayer Inc.
14.3.4 Abbott
14.3.5 Allergan
14.3.6 Bausch & Lomb
14.3.7 Johnson & Johnson
14.3.8 Rohto Pharmaceutical
14.3.9 The United Laboratories
14.3.10 Alcon
14.3.11 Novax Pharma
14.3.12 Rohto
14.3.13 Clear Eyes
14.3.14 Thea Pharmaceuticals
14.3.15 Scope Ophthalmics Ltd
14.3.16 Prestige Consumer Healthcare
14.3.17 Medicom Healthcare Ltd
14.3.18 Altacor
14.3.19 Optrex
14.3.20 Sager Pharma
